Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 1
1(20.0%)
5Total
N/A(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07290673Not ApplicableNot Yet Recruiting

Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers

Role: collaborator

NCT04796350Not ApplicableRecruiting

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

Role: collaborator

NCT06843577Not ApplicableRecruiting

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

Role: collaborator

NCT04483297Phase 1Terminated

First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)

Role: collaborator

NCT04016610Not ApplicableCompleted

Proof of Concept (POC) Study of the Soliton's Acoustic Scar Reduction (ASR) Treatment for the Treatment of Keloid Scar

Role: collaborator

All 5 trials loaded